Earnings Data
Report Date
Nov 05, 2026After Close (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
-0.13Last Year’s EPS
-0.27Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
DE:4E2 Q2 2026 Earnings Report
DE:4E2 Upcoming Earnings
Relmada Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
DE:4E2 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:4E2 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 06, 2026 | €4.54 | €4.60 | +1.32% |
May 12, 2026 | €6.00 | €6.45 | +7.50% |
Mar 19, 2026 | €5.55 | €5.30 | -4.50% |
Nov 13, 2025 | €3.34 | €3.08 | -7.78% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Relmada Therapeutics Inc (DE:4E2) report earnings?
Relmada Therapeutics Inc (DE:4E2) is schdueled to report earning on Nov 05, 2026, After Close (Confirmed).
What is Relmada Therapeutics Inc (DE:4E2) earnings time?
Relmada Therapeutics Inc (DE:4E2) earnings time is at Nov 05, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Relmada Therapeutics Inc stock?
The P/E ratio of Relmada Therapeutics is N/A.
What is DE:4E2 EPS forecast?
DE:4E2 EPS forecast for the fiscal quarter 2026 (Q3) is -0.13.